Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06527456
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2023-10-20
Brief Title:
Intervention With General Practitioners to Improve Womens Participation in Cervical Cancer Screening
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Intervention With General Practitioners to Improve Womens Participation in Cervical Cancer Screening
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INDIGO
Brief Summary:
In France cervical cancer is the 12th most common female cancer with nearly 3000 new cases per year
Since 2018 a national Organized Cervical Cancer Screening program DOCCU has been set up and concerns all asymptomatic women aged 25 to 65
This program managed by the Regional Cancer Screening Coordination Centers CRCDC invites women who have not taken a sample within the recommended time frame to consult for screening However only 59 of patients participated
The intervention of the general practitioner an essential player in prevention could allow for better awareness
The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening
Since 2018 a national Organized Cervical Cancer Screening program DOCCU has been set up and concerns all asymptomatic women aged 25 to 65
This program managed by the Regional Cancer Screening Coordination Centers CRCDC invites women who have not taken a sample within the recommended time frame to consult for screening However only 59 of patients participated
The intervention of the general practitioner an essential player in prevention could allow for better awareness
The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening
Detailed Description:
This is a cluster-randomized trial Randomization will be performed at the GP practice level to limit the potential contamination bias between doctors within the same practice GP practices will be randomized either to the usual practice arm or the intervention arm
If they are in the intervention group they or one of the professionals in their team will contact the patient phone call SMS email etc to encourage her to make an appointment to carry out the screening Contact arrangements are left to the discretion of each general practitioner
If they are in the Usual practice group they will use their usual practices to encourage screening
If they are in the intervention group they or one of the professionals in their team will contact the patient phone call SMS email etc to encourage her to make an appointment to carry out the screening Contact arrangements are left to the discretion of each general practitioner
If they are in the Usual practice group they will use their usual practices to encourage screening
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None